Numerous experimental and clinical observations have shown that IL-22 plays a critical role in the control of mucosal injury and inflammation including pneumonia and ALI.3 This study further demonstrates that lung ILC3s are the major contributors of innate IL-22, which displays protective actions against neutrophilic inflammation in the airway. The gene discussed is IL22; the disease is pneumonia.